Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in MRK — Merck & Co., Inc.

CIK 1603466 STAMFORD, CT
Back to MRK Full portfolio

Position in MRK

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$110,796,352
-$30,088,789 QoQ
Shares Held
921,077
-31.2% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Derivatives in MRK

reported options exposure · as of Mar 31, 2026
CallValue
$19,763,647
CallShares
164,300
PutValue
$8,263,923
PutShares
68,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Point72 Asset Management, L.P. holds $795,359,411 across 11 Drug Manufacturers - General names. MRK ranks #4 (13.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AZN
Astrazeneca PLC
 1,233,965 $243,362,577
2 BIIB
Biogen Inc.
 809,617 $148,427,084
3 PFE
Pfizer Inc
 4,365,063 $122,570,969
4 MRK
Merck & Co., Inc.
This page 		921,077 $110,796,352
5 LLY
ELI LILLY & Co
 95,766 $88,082,693
6 NVS
Novartis AG
 283,837 $43,356,101
7 BMY
Bristol Myers Squibb Co
 531,198 $32,217,158
8 AMRN
Amarin Corp Plc\Uk
 240,761 $3,481,404

All Filings in MRK

Export CSV
48 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,263,923 68,700
2026-03-31 $110,796,352 921,077
2026-03-31 $19,763,647 164,300
2025-12-31 $68,640,046 652,100
2025-12-31 $140,885,141 1,338,449
2025-12-31 $6,505,068 61,800
2025-09-30 $37,113,846 442,200
2025-09-30 $3,978,282 47,400
2025-09-30 $105,982,859 1,262,753
2025-06-30 $641,196 8,100
2025-06-30 $459,128 5,800
2025-06-30 $22,829,744 288,400
2025-03-31 $9,155,520 102,000
2025-03-31 $17,575,008 195,800
2024-12-31 $198,960 2,000
2024-12-31 $6,784,536 68,200
2024-09-30 $6,177,664 54,400
2024-09-30 $11,583,120 102,000
2024-06-30 $247,600 2,000
2024-06-30 $2,921,680 23,600
2024-03-31 $3,351,530 25,400
2024-03-31 $263,900 2,000
2023-12-31 $18,664,224 171,200
2023-12-31 $186,188,280 1,707,836
2023-12-31 $218,040 2,000
2023-09-30 $4,066,525 39,500
2023-09-30 $26,597,338 258,352
2023-09-30 $13,002,585 126,300
2023-06-30 $76,283,636 661,094
2023-03-31 $702,174 6,600
2023-03-31 $66,703,551 626,972
2022-12-31 $3,694,635 33,300
2022-12-31 $39,151,259 352,873
2022-12-31 $6,102,250 55,000
2022-09-30 $51,224,176 594,800
2022-06-30 $109,075,788 1,196,400
2022-03-31 $293,903,100 3,582,000
2022-03-31 $188,304,750 2,295,000
2021-12-31 $3,996,699 52,149
2021-09-30 $67,599,000 900,000
2021-09-30 $179,234,993 2,386,300
2021-06-30 $119,174,748 1,532,400
2021-06-30 $69,993,000 900,000
2021-03-31 $116,223,536 1,580,000
2021-03-31 $36,779,600 500,000
2020-12-31 $125,938,224 1,613,488
2020-09-30 $122,165,223 1,543,449
2020-06-30 $265,385,311 3,596,582

Report a Problem

Category
Description
Email (optional, for follow-up)